Key points are not available for this paper at this time.
Researching his latest book, Ray Moynihan uncovered how drug companies helped construct the scientific building blocks of a new condition. Here he asks whether we need a fresh approach to defining disease
Ruby Moynihan (Thu,) studied this question.